Skip to content

Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture

Intermittent Pneumatic Compression Effects on Venous Thromboembolism Incidence and Healing of Achilles Tendon Rupture

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01317160
Enrollment
150
Registered
2011-03-17
Start date
2011-03-31
Completion date
2018-09-30
Last updated
2024-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rupture, Surgical Wound Infection, Venous Thromboembolism, Venous Thrombosis

Keywords

Achilles Tendon, Immobilization, Wound Healing, Intermittent Pneumatic Compression, Ultrasonography, Microdialysis

Brief summary

This prospective randomized study aims to determine whether intermittent pneumatic compression (IPC), 75 patients, beneath functional bracing compared to treatment-as-usual in plaster cast, 75 patients, can reduce the Venous Thromboembolism (VTE) incidence and promote healing of sutured acute Achilles tendon ruptures. At two weeks post surgery, the IPC intervention will be ended and both patient groups will be immobilized in an orthosis until follow-up at six weeks. The endpoint of the first part of the study is VTE events. The primary outcome will be the DVT-incidence at two weeks, assessed using screening compression duplex ultrasound (CDU) by two ultrasonographers masked to the treatment allocation. Secondary outcome will be the DVT-incidence at 6 weeks. 1\) Deep Vein Thrombosis (DVT) detected by CDU , 2) isolated calf muscle vein thrombosis (ICMVT) detected by CDU, 3) symptomatic DVT or ICMVT detected by CDU, 4) symptomatic pulmonary embolism detected by computer tomography. The endpoint of the second part of the study is tendon healing quantified at 2 weeks by microdialysis followed by quantification of markers for tendon repair. The endpoint of the third part of the study is the functional outcome of the patients at one year post-operatively using four reliable and valid scores, i.e. the Achilles tendon Total Rupture Score (ATRS), Physical Activity scale (PAS), Foot and Ankle Outcome Score (FAOS) and EuroQol Group's questionnaire (EQ-5D) as well as the validated heel-rise test.

Detailed description

The incidence of DVT after Achilles tendon rupture is as high as 30-40% and patients exhibit a prolonged healing process with variable outcome. Moreover, it has been demonstrated that low molecular weight heparin had no effect on preventing DVT after Achilles tendon surgery. Whether intermittent pneumatic compression (IPC) can prevent DVTs and improve healing after Achilles tendon rupture has to our knowledge not been tested before.

Interventions

6 hours IPC, daily, applied to both calves during two weeks post-operatively. The VenaFlow Elite system (Aircast, Vista, California) uses calf cuffs containing two overlapping air chambers located posteriorly on the leg. As the device cycles, the distal chamber inflates to 52 mm Hg over half a second. During the last 0.2 second of this period, the proximal chamber inflates and reaches 45 mm Hg. After six seconds of inflation the cuff deflates, and the cycle is repeated every minute.

Sponsors

Region Stockholm
CollaboratorOTHER_GOV
DJO Incorporated
CollaboratorINDUSTRY
Karolinska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Achilles tendon rupture operated on within 96 hours of diagnose.

Exclusion criteria

1. Inability or refusal to give informed consent for participation in the study 2. Ongoing treatment with anticoagulant therapy 3. Inability to comply with the study instructions 4. Known kidney disorder 5. Heart failure with pitting oedema 6. Thrombophlebitis 7. Recent thromboembolic event (during the preceding 3 months) 8. Recent surgery (during the preceding month) 9. Presence of known malignancy 10. Current bleeding disorder 11. Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Venous Thromboembolic Events (VTE)2 weeksAt 2 weeks postoperatively the number of participants with VTE events will be assessed by: 1\) DVT detected by compression duplex ultrasound (CDU) , 2) isolated calf muscle vein thrombosis (ICMVT) detected by CDU, 3) symptomatic DVT or ICMVT detected by CDU, 4) symptomatic pulmonary embolism detected by computer tomography.

Secondary

MeasureTime frameDescription
Functional Outcome - Muscular Endurance Tests (Heel-rise)one yearThe functional outcome was assessed at 1year post-operatively by the validated calf muscle endurance test, i.e. heel rise test (Silbernagel KG et al. A new measurement of heel-rise endurance with the ability to detect functional deficits in patients with Achilles tendon rupture. Knee Surg Sports Traumatol Arthrosc. 2010). The Muscle lab linear encoder (Ergotest Technology, Oslo, Norway), was used for data collection. Standardized footwear was used. Patients warmed up before testing. During the heel-rise test, verbal encouragement was used. The patient was instructed to go as high as possible on each heel-rise with a straight knee. A metronome was used for standardized frequency of 30 heel-rises per minute. The test was terminated when the patient stopped or could not maintain frequency. For analysis, the limb symmetry index (LSI, percentage of injured vs. uninjured side) values were used.
Venous Thromboembolic Events (VTE)6 weeksAt 6 weeks postoperatively the number of participants with VTE events will be assessed by: 1\) DVT detected by compression duplex ultrasound (CDU) , 2) isolated calf muscle vein thrombosis (ICMVT) detected by CDU, 3) symptomatic DVT or ICMVT detected by CDU, 4) symptomatic pulmonary embolism detected by computer tomography.
Patient-reported OutcomeOne yearThe patients' symptoms will be assessed using the Achilles tendon Total Rupture Score (0-100, 100=best)
Microdialysis2 weeksAt 2 weeks postoperatively in-vivo microdialysis will be performed on as described by Greve et al 2012 (DOI: 10.1111/j.1600-0838.2012.01475.x). In the microdialysate substances will be assessed, eg. markers of tendon callus production, procollagen type I (PINP), by enzymatic quantification.
Time From Injury to Surgery1 yearPrognostic factor: Time to surgery , i.e. the time from ATR injury to start of the surgical procedure, will be calculated by using the time-point at which the patient sustained the injury as described in the patient journal, as well as the starting time point of the surgery as registered in the computerized operation report.

Other

MeasureTime frameDescription
Surgeon SexSurgery will be performed within 10 days of injuryPrognostic factor: All patients are operated on according to a standardized surgical protocol. and the surgeon on duty will perform the surgical repair and no specific surgeon can be selected by the patients. Unknown sex of the operating surgeon will be included as an additional exclusion criterion in the study.
Surgeon ExperienceSurgery will be performed within 10 days of injuryPrognostic factor: All patients are operated on according to a standardized surgical protocol. and the surgeon on duty will perform the surgical repair and no specific surgeon can be selected by the patients. The experienced group of surgeons will consist of specialists accredited with a specialist licence issued by The Swedish National Board of Health and Welfare. The less experienced group of surgeons will consist of residents.

Countries

Sweden

Participant flow

Participants by arm

ArmCount
Routine Care: Plaster Cast Treatment
Two weeks of postoperative conventional lower limb plaster cast immobilization in 30 degrees of plantarflexion
71
Intermittent Pneumatic Compression (IPC)
Two weeks of calf IPC by Aircast® VenaFlow® Elite System during immobilization in an orthosis Aicast® XP Walker. Intermittent pneumatic compression (IPC): 6 hours IPC, daily, applied to both calves during two weeks post-operatively. The VenaFlow Elite system (Aircast, Vista, California) uses calf cuffs containing two overlapping air chambers located posteriorly on the leg. As the device cycles, the distal chamber inflates to 52 mm Hg over half a second. During the last 0.2 second of this period, the proximal chamber inflates and reaches 45 mm Hg. After six seconds of inflation the cuff deflates, and the cycle is repeated every minute.
69
Total140

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyIncorrect inclusion11
Overall StudyLost to Follow-up33
Overall StudyWithdrawal by Subject02

Baseline characteristics

CharacteristicTotalIntermittent Pneumatic Compression (IPC)Routine Care: Plaster Cast Treatment
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants0 Participants1 Participants
Age, Categorical
Between 18 and 65 years
139 Participants69 Participants70 Participants
Age, Continuous40.4 years40.9 years39.9 years
Body mass index26.9 Kg/m/m27.1 Kg/m/m26.7 Kg/m/m
Region of Enrollment
Sweden
140 participants69 participants71 participants
Sex: Female, Male
Female
21 Participants8 Participants13 Participants
Sex: Female, Male
Male
119 Participants61 Participants58 Participants
Tobacco user
Tobacco user: No
127 participants64 participants63 participants
Tobacco user
Tobacco user: Yes
13 participants5 participants8 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
5 / 713 / 69
serious
Total, serious adverse events
0 / 710 / 71

Outcome results

Primary

Venous Thromboembolic Events (VTE)

At 2 weeks postoperatively the number of participants with VTE events will be assessed by: 1\) DVT detected by compression duplex ultrasound (CDU) , 2) isolated calf muscle vein thrombosis (ICMVT) detected by CDU, 3) symptomatic DVT or ICMVT detected by CDU, 4) symptomatic pulmonary embolism detected by computer tomography.

Time frame: 2 weeks

Population: Non-compliance was defined by exposure to less than ten hours of IPC. Therefore, two patients were withdrawn on this basis and the treatment group comprised 67 patients at final analysis.

ArmMeasureValue (NUMBER)
Routine Care: Plaster Cast TreatmentVenous Thromboembolic Events (VTE)26 participants
Intermittent Pneumatic Compression (IPC)Venous Thromboembolic Events (VTE)14 participants
Comparison: Domeij-Arverud et al., Bone Joint J 2015;97-B:675-80.p-value: 0.042Chi-squared
p-value: <0.0595% CI: [1.25, 6.32]Regression, Logistic
Secondary

Functional Outcome - Muscular Endurance Tests (Heel-rise)

The functional outcome was assessed at 1year post-operatively by the validated calf muscle endurance test, i.e. heel rise test (Silbernagel KG et al. A new measurement of heel-rise endurance with the ability to detect functional deficits in patients with Achilles tendon rupture. Knee Surg Sports Traumatol Arthrosc. 2010). The Muscle lab linear encoder (Ergotest Technology, Oslo, Norway), was used for data collection. Standardized footwear was used. Patients warmed up before testing. During the heel-rise test, verbal encouragement was used. The patient was instructed to go as high as possible on each heel-rise with a straight knee. A metronome was used for standardized frequency of 30 heel-rises per minute. The test was terminated when the patient stopped or could not maintain frequency. For analysis, the limb symmetry index (LSI, percentage of injured vs. uninjured side) values were used.

Time frame: one year

ArmMeasureGroupValue (MEAN)Dispersion
Routine Care: Plaster Cast TreatmentFunctional Outcome - Muscular Endurance Tests (Heel-rise)LSI of Eccentric power (W)78.2 Index of Injured versus uninjured sideStandard Deviation 15.8
Routine Care: Plaster Cast TreatmentFunctional Outcome - Muscular Endurance Tests (Heel-rise)LSI of total concentric work (J)66.8 Index of Injured versus uninjured sideStandard Deviation 22.2
Routine Care: Plaster Cast TreatmentFunctional Outcome - Muscular Endurance Tests (Heel-rise)LSI of Heel-rise repetitions83.0 Index of Injured versus uninjured sideStandard Deviation 22.5
Routine Care: Plaster Cast TreatmentFunctional Outcome - Muscular Endurance Tests (Heel-rise)LSI of concentric power (W)81.3 Index of Injured versus uninjured sideStandard Deviation 24.3
Routine Care: Plaster Cast TreatmentFunctional Outcome - Muscular Endurance Tests (Heel-rise)LSI of average height of heel-rise78.5 Index of Injured versus uninjured sideStandard Deviation 14.6
Intermittent Pneumatic Compression (IPC)Functional Outcome - Muscular Endurance Tests (Heel-rise)LSI of concentric power (W)74.2 Index of Injured versus uninjured sideStandard Deviation 32.3
Intermittent Pneumatic Compression (IPC)Functional Outcome - Muscular Endurance Tests (Heel-rise)LSI of average height of heel-rise82.5 Index of Injured versus uninjured sideStandard Deviation 17
Intermittent Pneumatic Compression (IPC)Functional Outcome - Muscular Endurance Tests (Heel-rise)LSI of Eccentric power (W)82.6 Index of Injured versus uninjured sideStandard Deviation 22.9
Intermittent Pneumatic Compression (IPC)Functional Outcome - Muscular Endurance Tests (Heel-rise)LSI of Heel-rise repetitions84.1 Index of Injured versus uninjured sideStandard Deviation 19.1
Intermittent Pneumatic Compression (IPC)Functional Outcome - Muscular Endurance Tests (Heel-rise)LSI of total concentric work (J)69.4 Index of Injured versus uninjured sideStandard Deviation 20.1
Secondary

Microdialysis

At 2 weeks postoperatively in-vivo microdialysis will be performed on as described by Greve et al 2012 (DOI: 10.1111/j.1600-0838.2012.01475.x). In the microdialysate substances will be assessed, eg. markers of tendon callus production, procollagen type I (PINP), by enzymatic quantification.

Time frame: 2 weeks

Population: Concentration of procollagen type I (PINP) ng/ml.

ArmMeasureValue (MEAN)Dispersion
Routine Care: Plaster Cast TreatmentMicrodialysis2.05 ng/mLStandard Deviation 0.78
Intermittent Pneumatic Compression (IPC)Microdialysis3.47 ng/mLStandard Deviation 1.81
Secondary

Patient-reported Outcome

The patients' symptoms will be assessed using the Achilles tendon Total Rupture Score (0-100, 100=best)

Time frame: One year

Population: Achilles tendon Total Rupture Score (0-100, 100=best outcome) is presented here.

ArmMeasureValue (MEAN)Dispersion
Routine Care: Plaster Cast TreatmentPatient-reported Outcome78 score on a scaleStandard Deviation 19.3
Intermittent Pneumatic Compression (IPC)Patient-reported Outcome77.8 score on a scaleStandard Deviation 17.2
Secondary

Time From Injury to Surgery

Prognostic factor: Time to surgery , i.e. the time from ATR injury to start of the surgical procedure, will be calculated by using the time-point at which the patient sustained the injury as described in the patient journal, as well as the starting time point of the surgery as registered in the computerized operation report.

Time frame: 1 year

ArmMeasureValue (MEAN)Dispersion
Routine Care: Plaster Cast TreatmentTime From Injury to Surgery62.33 hoursStandard Deviation 24.45
Intermittent Pneumatic Compression (IPC)Time From Injury to Surgery62.18 hoursStandard Deviation 26.19
Secondary

Venous Thromboembolic Events (VTE)

At 6 weeks postoperatively the number of participants with VTE events will be assessed by: 1\) DVT detected by compression duplex ultrasound (CDU) , 2) isolated calf muscle vein thrombosis (ICMVT) detected by CDU, 3) symptomatic DVT or ICMVT detected by CDU, 4) symptomatic pulmonary embolism detected by computer tomography.

Time frame: 6 weeks

ArmMeasureValue (NUMBER)
Routine Care: Plaster Cast TreatmentVenous Thromboembolic Events (VTE)34 participants
Intermittent Pneumatic Compression (IPC)Venous Thromboembolic Events (VTE)36 participants
p-value: 0.737Chi-squared
Other Pre-specified

Surgeon Experience

Prognostic factor: All patients are operated on according to a standardized surgical protocol. and the surgeon on duty will perform the surgical repair and no specific surgeon can be selected by the patients. The experienced group of surgeons will consist of specialists accredited with a specialist licence issued by The Swedish National Board of Health and Welfare. The less experienced group of surgeons will consist of residents.

Time frame: Surgery will be performed within 10 days of injury

Other Pre-specified

Surgeon Sex

Prognostic factor: All patients are operated on according to a standardized surgical protocol. and the surgeon on duty will perform the surgical repair and no specific surgeon can be selected by the patients. Unknown sex of the operating surgeon will be included as an additional exclusion criterion in the study.

Time frame: Surgery will be performed within 10 days of injury

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026